Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2025-12-25 @ 3:56 PM
NCT ID:
NCT04846868
Pre Assignment Details:
All participants were screened for eligibility prior to participation in the trial. Participants attended a specialist site which ensured that they strictly met all inclusion and none of the exclusion criteria. Participants were not to be allocated to a treatment group if any of the entry criteria were violated.
Recruitment Details:
Randomized, placebo-controlled, double-blind, multicenter, multinational, 26-week, parallel group trial. Patients could roll-over to safety follow-up extension trial (study 1346-0014). A dedicated ocular sub-study was implemented in several countries participating in the trial to investigate the ocular safety of iclepertin in patients with schizophrenia.
Study:
NCT04846868
Study Brief:
Results Section:
NCT04846868